FDA approves drug to reduce risk of preterm birth in at-risk pregnant women

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA approves drug to reduce risk of preterm birth in at-risk pregnant women

FDA approves drug to reduce risk of preterm birth in at-risk pregnant women
Fri, 04 Feb 2011 07:14:00 -0600

The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth.


Manage your FDA Subscriptions:

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux